Ricerca
Didattica
Soluzioni
Accedi
IT
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Immunology
Antonin Saldmann has not added Biography.
If you are Antonin Saldmann and would like to personalize this page please email our Author Liaison for assistance.
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer.
ESMO open , 2017 | Pubmed ID: 28761757
Hopital Européen Georges Pompidou
Clémence Granier1,
Emeline Vinatier2,3,4,
Elia Colin2,3,
Marion Mandavit2,3,
Charles Dariane2,3,5,
Virginie Verkarre6,
Lucie Biard7,
Rami El Zein2,
Corinne Lesaffre2,
Isabelle Galy-Fauroux2,
Hélène Roussel2,3,6,
Eléonore De Guillebon8,
Charlotte Blanc2,3,
Antonin Saldmann4,
Cécile Badoual2,6,
Alain Gey*,4,
Éric Tartour*,2,4
1PARCC-INSERM U970, Université Paris Descartes,
2INSERM U970, Université Paris Descartes,
3, Equipe Labellisée Ligue Contre le Cancer,
4Department of Immunology, Hopital Européen Georges Pompidou,
5Department of Medical Urology, Hopital Européen Georges Pompidou,
6Department of Pathology, Hopital Européen Georges Pompidou,
7, Université Paris Diderot Paris 7,
8Department of medical oncology, Hopital Européen Georges Pompidou
Riservatezza
Condizioni di utilizzo
Politiche
Contattaci
SUGGERISCI JOVE ALLA BIBLIOTECA
Newsletter di JoVE
JoVE Journal
Raccolta di metodi
JoVE Encyclopedia of Experiments
Archivio
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Sportello unico per docenti
Autori
Personale delle biblioteche
Accesso
CHI SIAMO
Copyright © 2024 MyJoVE Corporation. Tutti i diritti riservati